How to manage Pseudomonas aeruginosa infections.

about

How to manage Pseudomonas aeruginosa infections.

Item

http://www.wikidata.org/entity/Q54977074

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

How to manage Pseudomonas aeruginosa infections.

@en

How to manage Pseudomonas aeruginosa infections.

@nl

type

Item

label

How to manage Pseudomonas aeruginosa infections.

@en

How to manage Pseudomonas aeruginosa infections.

@nl

prefLabel

How to manage Pseudomonas aeruginosa infections.

@en

How to manage Pseudomonas aeruginosa infections.

@nl

P1476

How to manage Pseudomonas aeruginosa infections

@en

P2093

Antony Croxatto

http://www.w3.org/2001/XMLSchema#string

Benoit Guery

http://www.w3.org/2001/XMLSchema#string

Matteo Bassetti

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

A functional classification scheme for beta-lactamases and its correlation with molecular structure

Gram negative wound infection in hospitalised adult burn patients--systematic review and metanalysis-

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa

Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS

The leading causes of death after burn injury in a single pediatric burn center

Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa.

Pseudomonas aeruginosa urinary tract infections in hospitalized patients: Mortality and prognostic factors.

P304

212527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7573/DIC.212527

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elda Righi

A Vena

P577

2018-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29872449

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

5978525

http://www.w3.org/2001/XMLSchema#string